<DOC>
	<DOCNO>NCT02808624</DOCNO>
	<brief_summary>This study evaluate prophylactic effect exogenous L-CARNOSINE Oxaliplatin induce peripheral neuropathy , Thus half patient receive L-CARNOSINE Oxaliplatin half receive L-CARNOSINE chemotherapy ( oxaliplatin ) , And neuropathy together oxidative stress marker assess end treatment duration ( three month ) .</brief_summary>
	<brief_title>L-carnosine Prophylactic Effect Oxaliplatin Induced Peripheral Neuropathy GIT Cancer Patients</brief_title>
	<detailed_description>Oxaliplatin cause peripheral neuropathy , L-CARNOSINE suppose prevent side effect possibly reduce oxidative stress enhance growth nerves.This study intend clarify effect mechanism action L-CARNOSINE preventing Oxaliplatin induce peripheral neuropathy cancer patient . Blood sample collect patient start chemotherapy end treatment duration ( 3 month ) oxidative stress marker measure sample</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients eligible enrolled study , meet follow criterion 1 . Elderly male female age ( ˃18 ˂60 ) . 2 . Cancer patient treat oxaliplatin first time ( dose 85 135mg/m2 ) administer every two three week 3 month . Excluded study patient follow Criteria : Suffering diabetes mellitus . Suffering peripheral neuropathy result disease drug . Suffering severe renal impairment ( CrCl ˂ 30 ml/min ) . Suffering epilepsy . Taking vitamin B . Who previously take Oxaliplatin chemotherapeutic agent cause peripheral neuropathy . Taking antidepressant MAOI 's . Taking NSAIDs , paracetamol , opiates analgesic pain killer . Pregnant lactating patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Oxaliplatin , peripheral neuropathy , L-CARNOSINE</keyword>
</DOC>